E
SpyGlass Pharma, Inc. SGP
$26.20 $1.034.09% NASDAQ
Recommendation
Dividend Power Score
Prev Close
Volume
Avg Vol (90D)
Market Cap
Dividend & Yield
--
52-Week Range
P/E (TTM)
--
EPS (TTM)

06/30/2026 03/31/2026 06/30/2025
Total Cash And Short-Term Investments -6.70% 133.63% --
Total Receivables 3.83% 51.51% --
Inventory -- -- --
Prepaid Expenses -6.44% 89.46% --
Finance Division Loans and Leases Current -- -- --
Total Finance Division Other Current Assets -- -- --
Other Current Assets -- -- --
Total Current Assets -6.67% 132.94% --

Total Current Assets -6.67% 132.94% --
Net Property, Plant & Equipment 46.71% 8.84% --
Long-term Investments -- -- --
Goodwill -- -- --
Total Other Intangibles -- -- --
Finance Div Loans & Leases LT -- -- --
Total Finance Div Other LT Assets -- -- --
Total Other Assets -3.80% -75.40% --
Total Assets -5.79% 123.00% --

Total Accounts Payable 18.24% 30.34% --
Total Accrued Expenses 95.35% -59.58% --
Short-term Debt -- -- --
Current Portion of Long-Term Debt/Capital Leases -- -- --
Finance Division Debt Current -- -- --
Total Finance Division Other Current Liabilities 56.72% -38.72% --
Total Other Current Liabilities 56.72% -38.72% --
Total Current Liabilities 41.55% -22.33% --

Total Current Liabilities 41.55% -22.33% --
Long-Term Debt -- -- --
Short-term Debt -- -- --
Capital Leases 1.56% 1.58% --
Finance Division Debt Non Current -- -- --
Total Finance Division Other Non Current Liabilities -- -- --
Total Other Liabilities -- -- --
Total Liabilities 33.78% -18.61% --

Common Stock & APIC 0.57% 6,155.90% --
Retained Earnings -16.76% -13.19% --
Treasury Stock & Other -- -- --
Total Common Equity -7.10% 353.06% --

Preferred Stock Redeemable -- -- --
Preferred Stock Non Redeemable -- -- --
Preferred Stock Convertible -- -- --
Preferred Stock, Others -- -- --
Total Preferred Equity -- -- --

Total Common Equity -7.10% 353.06% --
Total Preferred Equity -- -- --
Total Minority Interest -- -- --
Total Equity -7.10% 136.62% --